About the University

The Medical University of Bialystok is a modern, rapidly developing public university dedicated to serving society through the innovative education of medical professionals, the conduct of research and development- including implementation- at the highest international level, and the advancement of clinical practice in line with the progress of medical knowledge.

The university continuously invests in the development of its academic and teaching staff. Researchers undertake numerous internships, training courses, and study visits at leading global institutions. The number of international researchers collaborating with the university—representing rapidly developing global research centres- increases every year. These efforts translate into an increase in the academic output of the university's staff.

With 175 full professors, 179 associate professors, and 450 PhD holders out of a total of over 1,000 academic staff members, the University boasts one of the highest ratios in the country, placing it at the forefront of Polish higher education institutions. The staff at the Medical University of Białystok are experts in their respective fields, serving on scientific committees and journal editorial boards, as well as acting as national and regional consultants. This dynamic and creative faculty also represents immense potential for securing external funding- both for research and from EU sources—and for the commercialization of research findings.

The Medical University of Białystok is a pioneer and leader in research on artificial intelligence in medicine and in large-scale studies-spanning genomics, proteomics, metabolomics, radiomics, and bioinformatics—that contribute to its advancement. The University also conducts a population-based study involving 10,000 residents of Bialystok (the Białystok Plus Study), a project unique to this part of Europe. It carries out distinctive research programs focused on personalized medicine and lifestyle diseases. These projects have resulted in the creation of a database—unique on a European scale—containing whole-genome analysis results from hundreds of patients suffering from oncological conditions (such as lung and ovarian cancer) and other lifestyle diseases (including diabetes and obesity). The University is also a leader in high-quality biological sample banking. The collected data are being used to build the Polish HD Medicine Database, which aims to gain a profound understanding of the mechanisms underlying conditions such as cancer, cardiovascular disease, and metabolic disorders, as well as to identify new therapeutic targets.

In recent years, the Medical University of Bialystok has invested in unique research infrastructure, assembled multidisciplinary research teams, and trained top experts in innovative research. As a result, the university is the most experienced center for genome sequencing in Poland. MUB experts have analyzed thousands of samples on a large scale. The analyses cover not only metabolomes and genomes but also data regarding, among other factors, environment, lifestyle, family history, and treatment response.

The university collaborates with dozens of research institutions worldwide, including Hasselt University (Belgium), the University of Cambridge (UK), Texas Tech University Health Sciences Center El Paso (USA), CEU San Pablo University (Spain), Universitätsmedizin Greifswald (Germany), Shanghai Pulmonary Hospital at Tongji University (China), and the University of Turku (Finland).

The video about HD Medicine at Medical University of Bialystok

The university has an ultra-modern research and teaching base, with a state-of-the-art Teaching Hospital, the Euroregional Pharmacy Centre, Faculty of Health Sciences Didactic-Scientific Centre, the Clinical Research Centre, the Experimental Medicine Centre, the Innovation Research Centre, the Centre for Bioinformatics and Data Analysis, Molecular Imaging Laboratory, Centre for Psychiatry, Centre Futuri and Centre for Medical Simulation.

The confirmation of the significant position of the University are the scientific categories awarded awarded by the Ministry of Science and Higher Education (based on the evaluation of research activity for the years 2022–2025). The Medical University of Białystok (MUB) achieved the best overall result among Polish medical universities. MUB was awarded the highest possible category A+ in two disciplines. It is also worth noting that MUB was the only Polish medical university to receive the top A+ category in the discipline of medical sciences. Furthermore, MUB received this same highest A+ category in the discipline of health sciences, sharing the top spot in that field only with the Medical University of Wrocław. In the discipline of pharmaceutical sciences, MUB was awarded category B+, tying with five other medical universities; this was the third-highest category on the applicable rating scale.

Furthermore, the Medical University of Bialystok was the only Polish university to secure a prestigious grant to conduct doctoral studies under the COFUND scheme of the Marie Skłodowska-Curie Actions, part of the European Commission’s Horizon 2020 framework programme. In 2019, the University ranked 11th among all higher education institutions in the competition for "Research University" status.

Currently, over 6,400 students are enrolled in 18 medical degree programs, including approximately 400 studying in English. International students come from countries such as Norway, Sweden, the USA, Canada, Germany, Spain, and Saudi Arabia. More than 260 doctoral students are pursuing their studies at the Doctoral School.

See the video about English Division Students

What MUB offers in particular: Medical Analytics, Biostatistics, Dietetics, Electroradiology, Pharmacy, Physiotherapy, Cosmetology, Medicine, Dentistry, Speech Therapy with Phonoaudiology, Nursing, Midwifery, Emergency Medicine, Dental Technology, Dental Hygiene, Psychology and Public Health&Epidemiology, as well as postgraduate programmes.

The University graduates are well prepared to work with patients, attending to them and their wellbeing, respecting universal ethical principles; however, they are also qualified for a career in research, exploring the mysteries of science which can be thereafter put to practice.

There are study clubs and student organizations at the University, where students engage in clinical trials, learn certain practical skills, take part in scientific conferences, and pursue their academic interests.

The Medical University of Bialystok is open to cooperation with businesses in various industry sectors. A lot of inventions developed by MUB researchers are patent protected and have been commercialized. The latest of these include: a Medical Honey product based on propolis extract, delaying the development of brain glioblastoma; a preparation licensed by MUB to strengthen bees from LOB; artificial saliva; work on extract from a Bialowieza Forest fungus that fights colon cancer.

The University is headquartered in an eighteenth-century Baroque palace called the Versailles of the North, located in the city centre. There is the University campus, school buildings, two teaching hospitals, student dormitories and sports facilities nearby.

The Medical University of Bialystok has been recognized for years in all nationwide ranking lists as the best academic institution in this region of Poland.